Urology Consultants Limited 08201157 false 2022-11-01 2023-10-31 2023-10-31 The principal activity of the company is other human health activities. Digita Accounts Production Advanced 6.30.9574.0 true 08201157 2022-11-01 2023-10-31 08201157 2023-10-31 08201157 bus:OrdinaryShareClass1 2023-10-31 08201157 bus:OrdinaryShareClass2 2023-10-31 08201157 bus:OrdinaryShareClass3 2023-10-31 08201157 bus:OrdinaryShareClass4 2023-10-31 08201157 core:CurrentFinancialInstruments 2023-10-31 08201157 core:CurrentFinancialInstruments core:WithinOneYear 2023-10-31 08201157 core:FurnitureFittings 2023-10-31 08201157 core:OfficeEquipment 2023-10-31 08201157 bus:SmallEntities 2022-11-01 2023-10-31 08201157 bus:AuditExemptWithAccountantsReport 2022-11-01 2023-10-31 08201157 bus:AbridgedAccounts 2022-11-01 2023-10-31 08201157 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2023-10-31 08201157 bus:RegisteredOffice 2022-11-01 2023-10-31 08201157 bus:CompanySecretary1 2022-11-01 2023-10-31 08201157 bus:Director1 2022-11-01 2023-10-31 08201157 bus:OrdinaryShareClass1 2022-11-01 2023-10-31 08201157 bus:OrdinaryShareClass2 2022-11-01 2023-10-31 08201157 bus:OrdinaryShareClass3 2022-11-01 2023-10-31 08201157 bus:OrdinaryShareClass4 2022-11-01 2023-10-31 08201157 bus:PrivateLimitedCompanyLtd 2022-11-01 2023-10-31 08201157 core:FurnitureFittings 2022-11-01 2023-10-31 08201157 core:OfficeEquipment 2022-11-01 2023-10-31 08201157 countries:England 2022-11-01 2023-10-31 08201157 2022-10-31 08201157 core:FurnitureFittings 2022-10-31 08201157 core:OfficeEquipment 2022-10-31 08201157 2021-11-01 2022-10-31 08201157 2022-10-31 08201157 bus:OrdinaryShareClass1 2022-10-31 08201157 bus:OrdinaryShareClass2 2022-10-31 08201157 bus:OrdinaryShareClass3 2022-10-31 08201157 bus:OrdinaryShareClass4 2022-10-31 08201157 core:CurrentFinancialInstruments 2022-10-31 08201157 core:CurrentFinancialInstruments core:WithinOneYear 2022-10-31 08201157 core:FurnitureFittings 2022-10-31 08201157 core:OfficeEquipment 2022-10-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 08201157

Urology Consultants Limited

Annual Report and Unaudited Abridged Financial Statements

for the Year Ended 31 October 2023

 

Urology Consultants Limited

Contents

Company Information

1

Director's Report

2

Abridged Profit and Loss Account

3

Abridged Balance Sheet

4

Notes to the Unaudited Abridged Financial Statements

5 to 7

 

Urology Consultants Limited

Company Information

Director

Jeremy Ockrim

Company secretary

Catriona Hollen

Registered office

Anglo House
Worcester Road
Stourport on Severn
DY13 9AW

Accountants

Perrigo Consultants Limited
Anglo House
Worcester Road
Stourport on Severn
DY13 9AW

 

Urology Consultants Limited

Director's Report for the Year Ended 31 October 2023

The report and the abridged financial statements for the year ended 31 October 2023.

Director of the company

The director who held office during the year was as follows:

Jeremy Ockrim

Principal activity

The principal activity of the company is other human health activities.

Small companies provision statement

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved by the director on 30 October 2024 and signed on its behalf by:

Jeremy Ockrim
Director

   
     
 

Urology Consultants Limited

Abridged Profit and Loss Account for the Year Ended 31 October 2023

Note

2023
£

2022
£

Gross profit

 

434,838

426,198

Administrative expenses

 

(147,658)

(121,079)

Profit before tax

4

287,180

305,119

Tax on profit

 

(63,050)

(57,889)

Profit for the financial year

 

224,130

247,230

The above results were derived from continuing operations.

The company has no recognised gains or losses for the year other than the results above.

 

Urology Consultants Limited

(Registration number: 08201157)
Abridged Balance Sheet as at 31 October 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

5

8,663

9,510

Current assets

 

Debtors

6

204,724

101,101

Investments

7

121,968

-

Cash at bank and in hand

 

61,935

212,163

 

388,627

313,264

Creditors: Amounts falling due within one year

(64,857)

(60,713)

Net current assets

 

323,770

252,551

Total assets less current liabilities

 

332,433

262,061

Provisions for liabilities

-

(1,807)

Accruals and deferred income

 

(3,558)

(3,498)

Net assets

 

328,875

256,756

Capital and reserves

 

Called up share capital

8

400

400

Retained earnings

328,475

256,356

Shareholders' funds

 

328,875

256,756

For the financial year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Approved and authorised by the director on 30 October 2024
 

Jeremy Ockrim
Director

   
     
 

Urology Consultants Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 October 2023

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Anglo House
Worcester Road
Stourport on Severn
DY13 9AW

These financial statements were authorised for issue by the director on 30 October 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Urology Consultants Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 October 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixture & fittings

20% Reducing balance

Office equipment

25% Reducing balance

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.


Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 2 (2022 - 2).

4

Profit before tax

Arrived at after charging/(crediting)

2023
£

2022
£

Depreciation expense

2,836

3,105

 

Urology Consultants Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 October 2023

5

Tangible assets

Fixtures and fittings
£

Office equipment
£

Total
£

Cost or valuation

At 1 November 2022

7,618

26,774

34,392

Additions

-

1,989

1,989

At 31 October 2023

7,618

28,763

36,381

Depreciation

At 1 November 2022

6,816

18,066

24,882

Charge for the year

160

2,676

2,836

At 31 October 2023

6,976

20,742

27,718

Carrying amount

At 31 October 2023

642

8,021

8,663

At 31 October 2022

802

8,708

9,510

6

Debtors

Debtors includes £Nil (2022 - £Nil) due after more than one year.

7

Current asset investments

2023
£

2022
£

Other investments

121,968

-

8

Share capital

Allotted, called up and fully paid shares

2023

2022

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

A Ordinary of £1 each

100

100

100

100

B Ordinary of £1 each

100

100

100

100

C Ordinary of £1 each

100

100

100

100

400

400

400

400